NCT06745583 2026-04-09A Phase 2 Study to Assess the Safety of EI-1071 and the Effects of EI-1071 on Neuroinflammation in Alzheimer's Disease PatientsElixiron Immunotherapeutics (Hong Kong) Ltd.Phase 2 Recruiting15 enrolled
NCT06539169 2024-11-14FLOWER: Following Longitudinal Outcomes With Epidemiology for Rare DiseasesxCuresRecruiting1,000 enrolled
NCT05635266 2024-05-07Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research InitiativesSanguine BiosciencesRecruiting20,000 enrolled